Exbio — Research products — Antibodies — CD and related antigens — Anti-Hu SIGLEC10 Purified

Anti-Hu SIGLEC10 Purified

Regulatory status

RUO

Antigen

SIGLEC10

Clone

5G6

Format

Purified

Reactivity

Human

Application

ELISA, IP, IHC

Variant

0.1 mg

11-932-C100

In stock

154.00 USD

Variant

0.1 mg

11-932-C100

In stock

154.00 USD

Contact distributor

Product details

Description

Images

References

SDS download

Isotype

Mouse IgG1

Specificity

The mouse monoclonal antibody 5G6 recognizes an extracellular epitope of human SIGLEC10, a sialic acid-binding lectin expressed on subsets of human leucocytes.

Application

ELISA, IP, IHC

Reactivity

Human

Immunogen

SIGLEC10 extracellular domain fused with human IgG1 Fc fragment

Concentration

1 mg/ml

Preparation

Purified by protein-A affinity chromatography.

Formulation

Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

Storage and handling

Store at 2-8°C. Do not freeze.

The product is intended For Research Use Only. Diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.

Other names

PRO940, SGL2

Antigen description

SIGLEC10 is a CD33-related receptor of sialoglycans, expressed on eosinophils, monocytes, a subpopulation of NK cells, and at lower level on B cells. Its murine ortholog is Siglec G. SIGLEC10 seems to act as an immunomodulatory receptor, which binds to VAP-1, a glycoprotein expressed on endothelium under inflammatory conditions. Another ligand of SIGLEC10 is CD24, a marker of poorer prognosis in carcinomas.

Entrez Gene ID 89790

UniProt ID Q96LC7

ELISA analysis of human SIGLEC 10-Fc fusion protein (5 μg/ml) using mouse monoclonal antibody 5G6 (0.016 - 10 μg/ml).

Product specific references:

Stephenson HN, Mills DC, Jones H, Milioris E, Copland A, Dorrell N, Wren BW, Crocker PR, Escors D, Bajaj-Elliott M: Pseudaminic acid on Campylobacter jejuni flagella modulates dendritic cell IL-10 expression via Siglec-10 receptor: A novel flagellin-host interaction. J Infect Dis. 2014 Nov 1;210(9):1487-98.
PubMed

Nguyen DH, Ball ED, Varki A: Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs. Exp Hematol. 2006 Jun;34(6):728-35.
PubMed

Läubli H, Kawanishi K, Vazhappilly CG, Matar R, Merheb M, Siddiqui SS: Tools to study and target the Siglec-sialic acid axis in cancer. FEBS J. 2021 Nov;288(21):6206-6225.
PubMed

Bhamidipati K, Silberstein JL, Chaichian Y, Baker MC, Lanz TV, Zia A, Rasheed YS, Cochran JR, Robinson WH: CD52 is elevated on B cells of SLE patients and regulates B cell function. Front Immunol. 2021 Feb 4;11:626820.
PubMed

Munday J, Kerr S, Ni J, Cornish AL, Zhang JQ, Nicoll G, Floyd H, Mattei MG, Moore P, Liu D, Crocker PR: Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. Biochem J. 2001 Apr 15;355(Pt 2):489-97.
PubMed